GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Total Receivables

Perseus Proteomics (TSE:4882) Total Receivables : 円8.1 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Total Receivables?

Perseus Proteomics's Total Receivables for the quarter that ended in Sep. 2024 was 円8.1 Mil.


Perseus Proteomics Total Receivables Historical Data

The historical data trend for Perseus Proteomics's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Total Receivables Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Receivables
Get a 7-Day Free Trial 9.83 8.75 10.12 9.81 13.66

Perseus Proteomics Quarterly Data
Mar18 Mar19 Dec19 Mar20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.50 14.94 13.63 13.66 8.12

Perseus Proteomics Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables


Perseus Proteomics Total Receivables Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's Total Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Perseus Proteomics Business Description

Traded in Other Exchanges
N/A
Address
4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics Headlines

No Headlines